Back to News
Market Impact: 0.25

MDT Factor-Based Stock Analysis

MDTNDAQ
Company FundamentalsAnalyst InsightsInvestor Sentiment & PositioningMarket Technicals & FlowsHealthcare & BiotechCapital Returns (Dividends / Buybacks)
MDT Factor-Based Stock Analysis

Validea's guru fundamental report identifies Medtronic (MDT) as the highest-rated stock among its guru strategies by the Pim van Vliet Multi-Factor Investor model, which targets low volatility, strong momentum, and high net payout yields. Despite this, MDT's 75% rating is below the 80% threshold for 'some interest' in the strategy, with its momentum and net payout yield being neutral and its final rank failing, indicating it does not fully align with the model's strong investment criteria.

Analysis

According to a Validea fundamental report, Medtronic (MDT) is the highest-rated stock based on the Pim van Vliet Multi-Factor Investor model, which prioritizes low volatility, strong momentum, and high net payout yield. Despite this top ranking, MDT's composite score is 75%, falling short of the 80% threshold that indicates strategic interest from the model. The stock successfully passes the model's criteria for market capitalization and standard deviation, confirming its low-volatility profile. However, it registers a 'NEUTRAL' assessment for both 'Twelve Minus One Momentum' and 'Net Payout Yield,' two other key pillars of the strategy. Consequently, the stock ultimately receives a 'FAIL' on its final rank, indicating that its profile does not fully align with the model's criteria for investment, a sentiment reinforced by the mildly negative sentiment score of -0.2.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment